Analytical Data
-
Gene name
MYNN
- Application
-
Alternative Names
MYNN; MYNN_HUMAN; Myoneurin; OSZF; SBBIZ1; ZBTB31; Zinc finger and BTB domain containing protein 31 ; Zinc finger and BTB domain-containing protein 31; Zinc finger protein with BTB/POZ domain; ZNF902
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NPC7
-
Expression Region
1-610 aa
-
AA Sequence
MQYSHHCEHL LERLNKQREA GFLCDCTIVI GEFQFKAHRN VLASFSEYFG AIYRSTSENN VFLDQSQVKA DGFQKLLEFI YTGTLNLDSW NVKEIHQAAD YLKVEEVVTK CKIKMEDFAF IANPSSTEIS SITGNIELNQ QTCLLTLRDY NNREKSEVST DLIQANPKQG ALAKKSSQTK KKKKAFNSPK TGQNKTVQYP SDILENASVE LFLDANKLPT PVVEQVAQIN DNSELELTSV VENTFPAQDI VHTVTVKRKR GKSQPNCALK EHSMSNIASV KSPYEAENSG EELDQRYSKA KPMCNTCGKV FSEASSLRRH MRIHKGVKPY VCHLCGKAFT QCNQLKTHVR THTGEKPYKC ELCDKGFAQK CQLVFHSRMH HGEEKPYKCD VCNLQFATSS NLKIHARKHS GEKPYVCDRC GQRFAQASTL TYHVRRHTGE KPYVCDTCGK AFAVSSSLIT HSRKHTGEKP YICGICGKSF ISSGELNKHF RSHTGERPFI CELCGNSYTD IKNLKKHKTK VHSGADKTLD SSAEDHTLSE QDSIQKSPLS ETMDVKPSDM TLPLALPLGT EDHHMLLPVT DTQSPTSDTL LRSTVNGYSE PQLIFLQQLY
-
Molecular Weight
68.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYNN is a relatively novel protein that has garnered interest in the field of molecular biology due to its potential roles in various cellular processes, including cell signaling, proliferation, and differentiation. Research on MYNN has intensified in recent years as it has been implicated in several diseases, including cancer and neurological disorders. Studies suggest that MYNN may function as a modulator of key signaling pathways, contributing to tumorigenesis and the progression of certain brain diseases. Understanding its structure and function is crucial for deciphering its biological significance and therapeutic potential. Advanced techniques, such as recombinant protein expression and purification, are being employed to produce MYNN for further investigation. By elucidating the mechanisms through which MYNN influences cellular behavior, researchers aim to identify novel biomarkers or therapeutic targets that could lead to innovative treatment strategies for diseases where MYNN plays a critical role. The ongoing research on MYNN not only enhances our understanding of its fundamental biological roles but also paves the way for potential clinical applications that could improve patient outcomes in conditions associated with altered MYNN activity.
